Comera Life Sciences Holdings, Inc. (CMRAW) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Woburn, MA, 미국. 현재 CEO는 Michael G. Campbell CPA.
CMRAW 을(를) 보유 IPO 날짜 2020-12-21, 12 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $6.15K.
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
